Listed

SpyGlass Pharma, Inc.

SGPNasdaqCIK 1778922HealthcareFiscal year ends Dec 31

Share

Share this page

Story card, 1080 × 1920

Standardized line items from XBRL company facts, the last twelve quarters. Negative values are in parentheses. A figure marked d is derived from year-to-date figures.

Income statement

Operating income−$22.0m, Q2 FY2026
Net income−$19.9m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Research and development$m6.1Research and development, period not labelled, three months to 2025-03-31$6.1m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure7.3Research and development, period not labelled, three months to 2025-06-30$7.3m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure8.5Research and development, Q1 FY2026, three months to 2026-03-31$8.5m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure10.9Research and development, Q2 FY2026, three months to 2026-06-30$10.9m. XBRL concept us-gaap:ResearchAndDevelopmentExpense. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure
Operating income$m(7.4)Operating income, period not labelled, three months to 2025-03-31−$7.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure(9.3)Operating income, period not labelled, three months to 2025-06-30−$9.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure(15.4)Operating income, Q1 FY2026, three months to 2026-03-31−$15.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure(22.0)Operating income, Q2 FY2026, three months to 2026-06-30−$22.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure
Income tax$m0.0Income tax, period not labelled, three months to 2025-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure0.0Income tax, period not labelled, three months to 2025-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure0.0Income tax, Q1 FY2026, three months to 2026-03-31$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure0.0Income tax, Q2 FY2026, three months to 2026-06-30$0. XBRL concept us-gaap:IncomeTaxExpenseBenefit. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure
Net income$m(8.8)Net income, period not labelled, three months to 2025-03-31−$8.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure(8.7)Net income, period not labelled, three months to 2025-06-30−$8.7m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure(13.8)Net income, Q1 FY2026, three months to 2026-03-31−$13.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure(19.9)Net income, Q2 FY2026, three months to 2026-06-30−$19.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure
Diluted EPS$ per share(3.96)Diluted EPS, period not labelled, three months to 2025-03-31−$3.96 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure(3.81)Diluted EPS, period not labelled, three months to 2025-06-30−$3.81 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure(0.69)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$0.69 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure(0.59)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure
Basic EPS$ per share(3.96)Basic EPS, period not labelled, three months to 2025-03-31−$3.96 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure(3.81)Basic EPS, period not labelled, three months to 2025-06-30−$3.81 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure(0.69)Basic EPS, Q1 FY2026, three months to 2026-03-31−$0.69 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure(0.59)Basic EPS, Q2 FY2026, three months to 2026-06-30−$0.59 per share. XBRL concept us-gaap:EarningsPerShareBasic. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure

Balance sheet

Cash and equivalents$223.1m, Q2 FY2026
Shareholders' equity$232.4m, Q2 FY2026
Line itemUnitperiod not labelled2023-12-31period not labelled2024-12-31period not labelled2025-03-31period not labelled2025-06-30FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30
Cash and equivalents$mnot reported16.3Cash and equivalents, period not labelled, at 2024-12-31$16.3m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-K filed 2026-03-26, accession 0001778922-26-000020.Report this figurenot reportednot reported96.4Cash and equivalents, FY2025, at 2025-12-31$96.4m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure239Cash and equivalents, Q1 FY2026, at 2026-03-31$238.9m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure223Cash and equivalents, Q2 FY2026, at 2026-06-30$223.1m. XBRL concept us-gaap:CashAndCashEquivalentsAtCarryingValue. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure
Current assets$mnot reported17.4Current assets, period not labelled, at 2024-12-31$17.4m. XBRL concept us-gaap:AssetsCurrent. 10-K filed 2026-03-26, accession 0001778922-26-000020.Report this figurenot reportednot reported109Current assets, FY2025, at 2025-12-31$108.8m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure253Current assets, Q1 FY2026, at 2026-03-31$253.4m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure236Current assets, Q2 FY2026, at 2026-06-30$236.5m. XBRL concept us-gaap:AssetsCurrent. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure
Total assets$mnot reported23.3Total assets, period not labelled, at 2024-12-31$23.3m. XBRL concept us-gaap:Assets. 10-K filed 2026-03-26, accession 0001778922-26-000020.Report this figurenot reportednot reported116Total assets, FY2025, at 2025-12-31$115.9m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure258Total assets, Q1 FY2026, at 2026-03-31$258.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure243Total assets, Q2 FY2026, at 2026-06-30$243.4m. XBRL concept us-gaap:Assets. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure
Current liabilities$mnot reported7.8Current liabilities, period not labelled, at 2024-12-31$7.8m. XBRL concept us-gaap:LiabilitiesCurrent. 10-K filed 2026-03-26, accession 0001778922-26-000020.Report this figurenot reportednot reported8.6Current liabilities, FY2025, at 2025-12-31$8.6m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure6.7Current liabilities, Q1 FY2026, at 2026-03-31$6.7m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure9.4Current liabilities, Q2 FY2026, at 2026-06-30$9.4m. XBRL concept us-gaap:LiabilitiesCurrent. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure
Total liabilities$mnot reported11.2Total liabilities, period not labelled, at 2024-12-31$11.2m. XBRL concept us-gaap:Liabilities. 10-K filed 2026-03-26, accession 0001778922-26-000020.Report this figurenot reportednot reported10.2Total liabilities, FY2025, at 2025-12-31$10.2m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure8.3Total liabilities, Q1 FY2026, at 2026-03-31$8.3m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure11.1Total liabilities, Q2 FY2026, at 2026-06-30$11.1m. XBRL concept us-gaap:Liabilities. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure
Shareholders' equity$m(33.0)Shareholders' equity, period not labelled, at 2023-12-31−$33.0m. XBRL concept us-gaap:StockholdersEquity. 10-K filed 2026-03-26, accession 0001778922-26-000020.Report this figure(60.5)Shareholders' equity, period not labelled, at 2024-12-31−$60.5m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure(68.9)Shareholders' equity, period not labelled, at 2025-03-31−$68.9m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure(78.4)Shareholders' equity, period not labelled, at 2025-06-30−$78.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure(98.8)Shareholders' equity, FY2025, at 2025-12-31−$98.8m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure250Shareholders' equity, Q1 FY2026, at 2026-03-31$250.1m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure232Shareholders' equity, Q2 FY2026, at 2026-06-30$232.4m. XBRL concept us-gaap:StockholdersEquity. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure

Cash flow

Operating cash flow−$14.8m, Q2 FY2026
Capital expenditure$1.9m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Operating cash flow$m(8.2)Operating cash flow, period not labelled, three months to 2025-03-31−$8.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure(6.3)Operating cash flow, period not labelled, three months to 2025-06-30−$6.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001778922-26-000045. Derived: 6-month figure less the 3-month figure.Report this figure(13.5)Operating cash flow, Q1 FY2026, three months to 2026-03-31−$13.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure(14.8)Operating cash flow, Q2 FY2026, three months to 2026-06-30−$14.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-06, accession 0001778922-26-000045. Derived: 6-month figure less the 3-month figure.Report this figure
Capital expenditure$m0.2Capital expenditure, period not labelled, three months to 2025-03-31$164.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure0.1Capital expenditure, period not labelled, three months to 2025-06-30$52.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001778922-26-000045. Derived: 6-month figure less the 3-month figure.Report this figure0.7Capital expenditure, Q1 FY2026, three months to 2026-03-31$676.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure1.9Capital expenditure, Q2 FY2026, three months to 2026-06-30$1.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-06, accession 0001778922-26-000045. Derived: 6-month figure less the 3-month figure.Report this figure

Shares

Diluted shares (weighted)33.44m, Q2 FY2026
Line itemUnitperiod not labelled2025-03-31period not labelled2025-06-30Q1 FY20262026-03-31Q2 FY20262026-06-30
Diluted shares (weighted)m shares2.2Diluted shares (weighted), period not labelled, three months to 2025-03-312,229,637 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure2.3Diluted shares (weighted), period not labelled, three months to 2025-06-302,277,521 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure19.9Diluted shares (weighted), Q1 FY2026, three months to 2026-03-3119,927,848 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-05-14, accession 0001778922-26-000035.Report this figure33.4Diluted shares (weighted), Q2 FY2026, three months to 2026-06-3033,439,543 shares. XBRL concept us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure

Shares outstanding: 33.45mShares outstanding, period not labelled, at 2026-07-2933,447,979 shares. XBRL concept dei:EntityCommonStockSharesOutstanding. 10-Q filed 2026-08-06, accession 0001778922-26-000045.Report this figure at Jul 29, 2026, from the cover of the 10-Q filed Aug 6, 2026.

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:51 ET. Listed shows no prices and gives no investment advice.